Exploring the Antimitotic Potential of Benincasa Hispida Seed Extract on HepG2 Cells

E Navya Pravala1, Kiranmai Mandava2, Somnath De1

  • 1Department of Pharmacology, St Pauls College of Pharmacy, Hyderabad, Telangana, India.

Abstract

Insights

The ethanolic extract of Benincasa hispida seeds (EeBHS) demonstrates significant anticancer properties. This natural compound effectively inhibits cell division and proliferation, showing potential as a novel therapeutic agent.

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer remains a major global health challenge, driving the search for novel, safer therapeutics.
  • Medicinal plants, particularly phytochemicals, are increasingly recognized for their anticancer potential.

Purpose of the Study:

  • To investigate the antimitotic and antiproliferative effects of the ethanolic extract of Benincasa hispida seeds (EeBHS).
  • To evaluate EeBHS as a potential natural anticancer agent.

Main Methods:

  • Antimitotic activity assessed via Allium cepa root tip meristem test and seed germination assay.
  • Mitotic index and cell cycle distribution analyzed post-EeBHS treatment.
  • Antiproliferative activity evaluated using MTT assay on HepG2 liver cancer cell lines.

Main Results:

  • EeBHS exhibited dose-dependent suppression of mitotic activity in Allium cepa and seeds (p < 0.001).
  • Significant reduction in mitotic index observed in EeBHS-treated groups compared to controls.
  • Mitotic arrest indicated by increased prophase/metaphase cells; EeBHS showed potent cytotoxicity against HepG2 cells.

Conclusions:

  • EeBHS possesses significant antimitotic and antiproliferative properties.
  • Bioactive constituents like flavonoids, alkaloids, and phenolics likely contribute to EeBHS's anticancer effects.
  • EeBHS shows promise as a natural anticancer agent warranting further research.

Related Concept Videos